Back to Archived Journals » Hypoxia » Volume 5

KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation

Total article views   HTML views PDF downloads Totals
8,304 Dovepress* 7,998+ 793 8,791
PubMed Central* 306 103 409
Totals 8,304 896 9,200
*Since 23 May 2017

View citations on PubMed Central and Google Scholar